Ads
related to: vitreomacular adhesion treatments for dogsthefarmersdog.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
The adhesion in of itself is not dangerous, but the resulting pathological vitreomacular traction (VMT) can cause severe ocular damage. The current standard of care for treating these adhesions is pars plana vitrectomy (PPV), which involves surgically removing the vitreous from the eye.
Dogs with this kind of cancer that have surgery usually only survive 3 to 18 months, depending on how advanced the cancer is when found (1). Squamous cell carcinoma: This is a good possibility ...
Ocriplasmin, sold under the brand name Jetrea, is a recombinant protease with activity against fibronectin and laminin, components of the vitreoretinal interface.It is used for treatment of symptomatic vitreomacular adhesion, for which it received FDA approval on 17 October 2012.
pergolide – dopamine receptor agonist used for the treatment of pituitary pars intermedia dysfunction in horses; phenobarbital – anti-convulsant used for seizures; phenylbutazone – nonsteroidal anti-inflammatory drug (NSAID) phenylpropanolamine – controls urinary incontinence in dogs
Vitreomacular traction syndrome (VTS) is a medical condition in the eye that is the result of tractional forces (pulling) being placed on the retina. [ 1 ] [ 2 ] VTS is common in people who have an incomplete posterior vitreous detachment, a type of retinal detachment at the periphery of the retina. [ 1 ]
It is the company's first product in the market related to skin disease treatments for dogs, that include Zoetis' oral treatment Apoquel. In a head-to-head study conducted in 338 dogs, Zenrelia ...